CellCentric Funding: $220M Raised, Series D (2026)

CellCentric is based in Little Chesterford, United Kingdom. It has raised $220M in total funding. Latest round: Series D.

CellCentric funding overview

CellCentric is based in Little Chesterford, United Kingdom. CellCentric has raised $220M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in July 2026. The round record for CellCentric runs through 2026; nothing later has been disclosed. Investors on record include RA Capital Management, Forbion, Morningside, Pfizer Ventures, Avego, American Cancer Society. 6 distinct backers are named across the disclosed rounds.

CellCentric at a glance

Total raised
$220M
Latest round
Series D
Latest round date
July 2026
Headquarters
Little Chesterford, United Kingdom
Notable investors
RA Capital Management, Forbion, Morningside, Pfizer Ventures, Avego, American Cancer Society

Frequently asked about CellCentric funding

How much has CellCentric raised?
CellCentric has raised $220M in total disclosed funding across the rounds on record.
Who has invested in CellCentric?
RA Capital Management, Forbion, Morningside, Pfizer Ventures, Avego, American Cancer Society are named among the investors backing CellCentric.
What was the latest CellCentric funding round?
The most recent disclosed round is a Series D, announced in July 2026.
Where is CellCentric based?
CellCentric is based in Little Chesterford, United Kingdom.
When did CellCentric last raise?
The last disclosed CellCentric round closed in July 2026 at Series D.

CellCentric totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Little Chesterford below to benchmark round size and investor mix.

Companies related to CellCentric (18)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026